Prosecution Insights
Last updated: May 29, 2026

Examiner: CRAIG, KAILA ANGELIQUE

Tech Center 3600 • Art Units: 1615 1618 3646

This examiner grants 33% of resolved cases

Performance Statistics

32.8%
Allow Rate
-19.2% vs TC avg
111
Total Applications
+26.7%
Interview Lift
1317
Avg Prosecution Days
Based on 61 resolved cases, 2023–2026

Rejection Statute Breakdown

0.7%
§101 Eligibility
5.1%
§102 Novelty
81.8%
§103 Obviousness
1.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17634410 SMART PEPTIDES AND TRANSFORMABLE NANOPARTICLES FOR CANCER IMMUNOTHERAPY Final Rejection The Regents of the University of California
16970442 COMPOUNDS AND METHODS USEFUL IN BRACHYTHERAPY Non-Final OA North Carolina State University
19275772 ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF Final Rejection Fennec Pharmaceuticals, Inc.
17960867 SULFATE-FREE SHAMPOO COMPOSITION THAT FORMS LYOTROPIC LIQUID CRYSTALS UPON DILUTION Final Rejection The Procter & Gamble Company
16773540 MATERIALS AND METHODS FOR GENE DELIVERY IN THE HEART Final Rejection Northwestern University
18041587 COLON CANCER DIAGNOSIS OR DETECTION COMPOSITION FOR PREDICTING RESPONSE TO DRUG, AND COMPOSITION FOR PREVENTING OR TREATING COLON CANCER Final Rejection KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
17836403 NANOSATELLITE-SUBSTRATE COMPLEX AND METHOD OF REGULATING STEM CELL ADHESION AND DIFFERENTIATION USING THE SAME Non-Final OA Korea University Research and Business Foundation
17422667 ADHESIVE/ADSORPTION SWITCH ON NANOPARTICLES TO INCREASE TUMOR UPTAKE AND DELAY TUMOR CLEARANCE Final Rejection The Johns Hopkins University
19040987 DLL3-SPECIFIC BINDING CONSTRUCTS AND THEIR USE IN RADIOTHERAPY Final Rejection ORANO MED THERANOSTICS
17442905 TETRAPYRROLIC CONJUGATES AND USES THEREOF FOR IMAGING Non-Final OA The Research Foundation for The State University of New York
17321088 METHODS AND COMPOSITIONS FOR DETECTION AND VISUALIZATION OF OXIDATIVE STRESS-INDUCED CARBONYLATION IN CELLS Final Rejection The Research Foundation for The State University of New York
17600652 Biosynthesis of Selenium Nanoparticles Having Antimicrobial Activity Non-Final OA Northeastern University
18007254 POLYSACCHARIDE COMPRISING A CHELATING GROUP SOLUBLE AT PHYSIOLOGICALPH AND USE THEREOF Non-Final OA UNIVERSITE CLAUDE BERNARD LYON 1
18306986 PREPARATION OF NANO SILVER/DUAL MODIFIED CHITOSAN ANTIBACTERIAL HYDROGEL DRESSING WITH DISCOLORATION EFFECT FOR WOUND INFECTION JUDGEMENT AND HYDROGEL DRESSING PREPARED BY THE SAME Non-Final OA ZHEJIANG UNIVERSITY
17579470 Methods and kits for diagnosis of cancer and prediction of therapeutic value Non-Final OA CORNELL UNIVERSITY
18719175 METHOD FOR EXTRACTING A FLUORINATED GAS Non-Final OA Bracco Suisse SA
18018866 TOTAL SYNTHESES OF SPECIALIZED PRO-RESOLVING MEDIATORS (SPMS), STRUCTURAL ISOMERS AND STRUCTURAL ANALOGS Non-Final OA UNIVERSITÉ LAVAL
18315364 EXOSOME BASED ASSAYS FOR DETERMINING CANDIDATES FOR OSTEOARTHRITIS STEM CELL THERAPY Final Rejection CREATIVE MEDICAL TECHNOLOGIES, INC.
18313915 MELANOCORTIN TYPE 2 RECEPTOR (MC2R) TARGETED THERAPEUTICS AND USES THEREOF Non-Final OA Radionetics Oncology, Inc.
18299304 THERAPEUTIC RADIOLABELLED CONJUGATES AND THEIR USE IN THERAPY Non-Final OA UNIVERSITY OF SYDNEY
18025849 TROPHOBLAST GLYCOPROTEIN RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS Non-Final OA ACTINIUM PHARMACEUTICALS, INC.
18044309 FORMULATIONS OF CABAZITAXEL Non-Final OA Zhuhai Beihai Biotech Co., Ltd.
17618743 DISSACHARIDE FORMULATIONS FOR CONTROLLED DRUG RELEASE Non-Final OA TECHNICAL UNIVERSITY OF DENMARK
17294196 ORAL WASH FOR ORAL FLUID COLLECTION AND ANALYSIS AND METHODS OF USE THEREOF Final Rejection Decima Diagnostics, LLC
17293764 NANOPARTICLE COMPOSITIONS FOR THE TREATMENT OF PNEUMOCOCCAL INFECTIOS Non-Final OA LIVERPOOL JOHN MOORES UNIVERSITY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month